A clinical dilemma while treating hypercholesterolaemia in psoriasis [9]

British Journal of Dermatology

Volumn 149, Issue 6, 2003, Pages 1305-1306

  Jacobi, T C ^a   Highet, A ^a  

^a YORK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; CALCIPOTRIOL; CAPTOPRIL; CHLOROQUINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LISINOPRIL; LITHIUM; MOMETASONE FUROATE; NONSTEROID ANTIINFLAMMATORY AGENT; PRAVASTATIN; SERVASTATIN; SIMVASTATIN; STATIN; TAR; TAZAROTENE; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; DISEASE EXACERBATION; DIZZINESS; HUMAN; HYPERCHOLESTEROLEMIA; IATROGENIC DISEASE; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS; RECURRENT DISEASE; ULTRAVIOLET B RADIATION;

ADULT; ANTICHOLESTEREMIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; PSORIASIS;

EID: 0347356305     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05675.x     Document Type: Letter

References (6)

1. Wolf R, Ruocco V. Triggered psoriasis. Adv Exp Med Biol 1999; 455: 221-5.
2. Ashcroft DM, Li Wan Po A, Griffiths CEM. Therapeutic strategies for psoriasis. J Clin Pharm Ther 2000; 25: 1-10.
3. Abel E, DiCocco LM, Orendberg EK et al. Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986; 15: 1007-20.
4. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. Dislipidaemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001; 303: 33-9.
5. Proksch E. Antilipemic drug-induced skin manifestations. Hautarzt 1995; 46: 76-80.
6. Fisher DA, Elias PM, LeBoit PL. Exacerbation of psoriasis by the hypolipidemic agent, gemfibrozil. Arch Dermatol 1988; 124: 854-5.